From: Association between the APOE gene polymorphism and lipid profile and the risk of atrial fibrillation
Parameters | No. subjects | P | Non-adjusted OR(95 % CI) | P | Adjusted OR(95 % CI) |
---|---|---|---|---|---|
Age | Â | Â | Â | Â | Â |
(< 65y) | 396 |  | (Ref.) |  | (Ref.) |
(≥ 65y) | 971 | < 0.001 | 2.937(2.298–3.754) | < 0.001 | 2.848(1.894–4.283) |
DBP | Â | Â | Â | Â | Â |
(< 90mm Hg) | 952 |  | (Ref.) |  | (Ref.) |
(≥ 90mm Hg) | 415 | < 0.001 | 1.471(1.166–1.857) | 0.018 | 1.556(1.080–2.240) |
APOE-ε4 carrier |  |  |  |  |  |
no | 961 | Â | (Ref.) | Â | (Ref.) |
yes | 406 | 0.053 | 1.258(0.997–1.588) | 0.683 | 1.079(0.748–1.558) |
TC | Â | Â | Â | Â | Â |
(< 5.2mmol/L) | 1141 |  | (Ref.) |  | (Ref.) |
(≥ 5.2mmol/L) | 226 | < 0.001 | 4.305(3.066–6.045) | < 0.001 | 3.879(2.003–7.513) |
TG | Â | Â | Â | Â | Â |
(< 1.7mmol/L) | 1104 |  | (Ref.) |  | (Ref.) |
(≥ 1.7mmol/L) | 263 | < 0.001 | 1.823(1.382–2.406) | 0.028 | 1.596(1.053–2.419) |
LDL-C | Â | Â | Â | Â | Â |
(< 3.4mmol/L) | 1240 |  | (Ref.) |  | (Ref.) |
(≥ 3.4mmol/L) | 127 | < 0.001 | 6.522(3.913–10.872) | 0.596 | 1.308(0.485–3.527) |
Apo-B | Â | Â | Â | Â | Â |
(< 1.1 g/L) | 1242 |  | (Ref.) |  | (Ref.) |
(≥ 1.1 g/L) | 125 | < 0.001 | 3.983(2.550–6.222) | 0.459 | 1.380(0.589–3.233) |